Novel Modified GLP-1 Derivatives with Prolonged Glucose-Lowering Ability In Vivo

Novel Modified GLP-1 Derivatives with Prolonged Glucose-Lowering Ability In Vivo
复制标题

具有延长体内降糖能力的新型修饰 GLP-1 衍生物

DOI:
10.1007/s10989-019-09991-4
复制
发表时间:
2019-12
影响因子:
2.5
通讯作者:
Zhang Yunxiao
Zhang Yunxiao
中科院分区:
生物学4区
文献类型:
--
作者:
Liu Yu;Wang Qing;Nie Dongsong;Zhang Yuxia;Wang Zhen;Zhang Yunxiao

文献摘要

参考文献

相似文献

二肽基肽酶-IV(DPP-IV)对天然胰高血糖素样肽1(GLP-1)的快速降解为产生抗降解GLP-1类似物提供了新的方法。GLP-1类似物与HSA的化学偶联在本研究中创新性地通过固相肽合成实现,并且在体内显示出延长的降糖能力。GLP-1(7-37)(Ala 8Aib)-Cys-HSA通过固相肽合成通过两个水平的修饰构建:Ala 8突变为氨基异丁酸(Aib)以减少DPP-IV降解,以及通过化学修饰与大血清蛋白HSA缀合以减少肾滤过。本研究采用葡萄糖耐量试验和胰岛素分泌试验检测GLP-1(7-37)(Ala 8Aib)-Cys-HSA的体内生物学活性。在T2 DM大鼠中评价了长达4周的长效降糖和胰岛素释放作用。GLP-1(7-37)(Ala 8Aib)-Cys-HSA降低正常小鼠和T2 DM大鼠的血糖。在4周的研究期间,每天两次给予T2 DM大鼠GLP-1(7-37)(Ala 8Aib)-Cys-HSA显著降低IP葡萄糖激发后的血糖波动(P < 0.01至0.05),并大大增加胰岛素分泌。这些发现表明,白蛋白缀合的GLP-1类似物模拟天然GLP-1的功能,具有延长的活性。
The rapid degradation of native glucagon-like peptide 1 (GLP-1) by dipeptidyl peptidase-IV (DPP-IV) has advanced new approaches to the generation of degradation-resistant GLP-1 analogs. Chemical coupling of GLP-1 analog to HSA is innovatively achieved by solid-phase peptide synthesis in this study and shows prolonged glucose-lowering ability in vivo. GLP-1(7-37)(Ala8Aib)-Cys-HSA was constructed by solid-phase peptide synthesis through two levels of modification: mutation of Ala8 to aminoisobutyric acid (Aib) to decrease DPP-IV degradation, and conjugation to large serum protein HSA by chemical modification to decrease renal filtration. Glucose tolerance test and insulin secretion assay were performed to examine the biological activity of GLP-1(7-37)(Ala8Aib)-Cys-HSA in vivo in the present research. Long-lasting glucose-lowering and insulin-releasing effects were evaluated up to 4 weeks in T2DM rats. GLP-1(7-37)(Ala8Aib)-Cys-HSA lowered blood glucose in normal mice and T2DM rats. Twice administration of GLP-1(7-37)(Ala8Aib)-Cys-HSA to T2DM rats daily significantly reduced glycemic excursion following IP glucose challenge (P < 0.01 to 0.05) and greatly increased insulin secretion during the 4-week study period. These findings demonstrate that the albumin-conjugated GLP-1 analog mimics the function of native GLP-1 with prolonged activity.
DOI: 10.2146/ajhp140260
发表时间: 2015-07
期刊: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
影响因子: --
作者:
P. Davis;U. Ndefo;A. Oliver;E. Payton
通讯作者: P. Davis;U. Ndefo;A. Oliver;E. Payton
DOI: 10.1007/bf01316798
发表时间: 1993-04-01
影响因子: 3.1
作者:
WETTERGREN, A;SCHJOLDAGER, B;HOLST, JJ
通讯作者: HOLST, JJ
DOI: 10.1039/c39780000537
发表时间: 1978-01-01
影响因子: --
作者:
ATHERTON, E;FOX, H;WILLIAMS, BJ
通讯作者: WILLIAMS, BJ
DOI: 10.1007/bf03365101
发表时间: 2007-06
期刊: MMW - Fortschritte der Medizin
影响因子: --
作者:
K. Parhofer
通讯作者: K. Parhofer
DOI: 10.1210/endo.136.8.7628397
发表时间: 1995-08
期刊: Endocrinology
影响因子: 4.8
作者:
T. Kieffer;C. Mcintosh;R. Pederson
通讯作者: T. Kieffer;C. Mcintosh;R. Pederson